1-3 of 3
Françoise Praz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma

Javier Vaquero, Cindy Lobe, Sylvana Tahraoui, Audrey Clapéron, Martine Mergey, Fatiha Merabtene, Dominique Wendum, Cédric Coulouarn, Chantal Housset, Christèle Desbois-Mouthon, Françoise Praz, Laura Fouassier
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17): 4282–4296.
https://doi.org/10.1158/1078-0432.CCR-17-3725
Published: 04 September 2018
View articletitled, The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Open the PDF for The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract A38: IMODI initiative: a novel holistic and integrative approach with patient-derived tumor models

Francoise LE VACON, Laurent Arnould, Alain Bruno, Loreley Calvet, Marc Colombel, Jill Corre, Olivier Cuvillier, Benedicte Eckel, Nico Forraz, Alexandra Gonzalez-Jouhanneaud, Dominique Guenot, Juan Iovanna, Mariana Kuras, Christophe Lautrette, Bernard Malavaud, Philippe Merle, Florence Meyer-Losic, Francoise Praz, Olivier Rosmorduc, Jean-Emmanuel Sarry, Severine Tabone, Philippe Vaglio, Loic Ysebaert, Olivier Duchamp
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): A38.
https://doi.org/10.1158/1557-3265.PDX16-A38
Published: 15 August 2016
View articletitled, Abstract A38: IMODI initiative: a novel holistic and integrative approach with patient-derived tumor models
Journal Articles

Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

Aziz Zaanan, Jean-François Fléjou, Jean-François Emile, Guetz Gaëtan Des, Peggy Cuilliere-Dartigues, David Malka, Cédric Lecaille, Pierre Validire, Christophe Louvet, Philippe Rougier, Aimery de Gramont, Franck Bonnetain, Françoise Praz, Julien Taïeb
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7470–7478.
https://doi.org/10.1158/1078-0432.CCR-11-1048
Published: 30 November 2011
View articletitled, Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Open the PDF for Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy in another window
Includes: Supplementary data